Organization and Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Company's Consolidated Statements of Operations

The table below shows a reconciliation of the Company’s net loss, including the significant expense categories regularly provided to and reviewed by the CODM, as computed under U.S. GAAP to the Company’s total consolidated net loss in the Consolidated Statements of Operations:

	For the Three Months Ended March 31,
	2025			2024
Sales	$	37,895		$	29,512
Cost of sales		9,566			8,827
Gross profit		28,329			20,685
Operating expenses:
Commercial		21,174			16,475
General and administrative		7,462			6,849
Research and development		9,056			6,150
Clinical & regulatory		1,311			1,881
Total operating expenses		39,003			31,355
Loss from operations		(10,674	)		(10,670	)
Other income (expense), net:
Interest expense		(6	)		(6	)
Interest and other income		2,508			1,585
Loss before income taxes		(8,172	)		(9,091	)
Income tax expense		18			9
Net loss	$	(8,190	)	$	(9,100	)